Insider Transactions in Q2 2024 at Natera, Inc. (NTRA)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 20
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
3,386
+1.44%
|
-
|
|
Apr 20
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
856
+0.41%
|
-
|
|
Apr 20
2024
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
190
+0.06%
|
-
|
|
Apr 16
2024
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
80,000
-22.35%
|
$7,200,000
$90.7 P/Share
|
|
Apr 15
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
6,816
-0.98%
|
$633,888
$93.67 P/Share
|
|
Apr 03
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
26,700
-2.63%
|
$2,456,400
$92.49 P/Share
|
|
Apr 02
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,378
-1.91%
|
$126,776
$92.62 P/Share
|